Journal of Bacteriology, April 1999, p. 2001-2007, Vol. 181, No. 7
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Rega Institute for Medical Research,
Received 23 December 1998/Accepted 19 January 1999
The serotype-specific, 5.9-kb region II of the Haemophilus
influenzae type a capsulation locus was sequenced and found to contain four open reading frames termed acs1 to
acs4. Acs1 was 96% identical to H. influenzae
type b Orf1, previously shown to have CDP-ribitol pyrophosphorylase
activity (J. Van Eldere, L. Brophy, B. Loynds, P. Celis, I. Hancock, S. Carman, J. S. Kroll, and E. R. Moxon, Mol. Microbiol.
15:107-118, 1995). Low but significant homology to other
pyrophosphorylases was only detected in the N-terminal part of Acs1,
whereas the C-terminal part was homologous to several short-chain
dehydrogenases/reductases, suggesting that Acs1 might be a bifunctional
enzyme. To test this hypothesis, acs1 was cloned in an
expression vector and overexpressed in Escherichia coli.
Cells expressing this protein displayed both ribitol 5-phosphate dehydrogenase and CDP-ribitol pyrophosphorylase activities, whereas these activities were not detectable in control cells. Acs1 was purified to near homogeneity and found to copurify with ribitol 5-phosphate dehydrogenase and CDP-ribitol pyrophosphorylase activities. These had superimposable elution profiles from DEAE-Sepharose and
Blue-Sepharose columns. The dehydrogenase activity was specific for
ribulose 5-phosphate and NADPH in one direction and for
ribitol 5-phosphate and NADP+ in the other direction and
was markedly stimulated by CTP. The pyrophosphorylase showed activity
with CTP and ribitol 5-phosphate or arabitol 5-phosphate. We conclude
that acs1 encodes a bifunctional enzyme that converts
ribulose 5-phosphate into ribitol 5-phosphate and further into
CDP-ribitol, which is the activated precursor form for incorporation of
ribitol 5-phosphate into the H. influenzae type a capsular polysaccharide.
*
Corresponding author. Mailing address: Rega Institute
for Medical Research, Catholic University of Leuven,
Minderbroedersstraat 10, B-3000 Leuven, Belgium. Phone: 32 16 337372. Fax: 32 16 337320. E-mail:
Johan.VanEldere{at}rega.kuleuven.ac.be.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |